Physician profile
Mickey D Stapp
NPI 1023114238
$109,822.19
in general payments reported to CMS, 2019-2025
49 companies · $28K in 2025
The $28K reported for 2025 was more than what 98% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,596 · 2020: $4,921 · 2021: $2,697 · 2022: $31K · 2023: $33K · 2024: $8,401 · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $57K · Travel and Lodging: $10K · Food and Beverage: $2,750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $56,525.00 |
| Travel and Lodging | $10,367.97 |
| Food and Beverage | $2,749.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $100,076.83 | 2020-2025 | |
| Tenex Health INC. | $4,375.00 | 2019-2020 | |
| Bioventus LLC | $489.98 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Horizon Therapeutics Plc | $470.18 | 2019-2022 | |
| Depuy Synthes Sales INC. | $429.88 | 2021-2025 | Na, Motoband, N/A |
| Smith+Nephew, INC. | $396.72 | 2019-2024 | Collagenase Santyl, Vlp Foot, Grafix Pl |
| Nevro Corp. | $352.17 | 2021-2024 | Senza |
| Stryker Corporation | $342.85 | 2021-2025 | Citrefix, Augment Injectable, Alphavent |
| Organogenesis INC. | $277.83 | 2020-2023 | Puraply |
| Melinta Therapeutics, LLC | $258.89 | 2021-2022 | |
| Ibsa Pharma INC. | $246.62 | 2021-2024 | Tirosint, Licart, Licart |
| Geistlich Pharma, North America, INC. | $235.12 | 2021-2023 | Bio-Gide |
| Team 1, LLC | $222.63 | 2023-2025 | |
| Crossroads Extremity Systems, LLC | $148.50 | 2020-2021 | |
| Dynasplint Systems INC. | $143.52 | 2019-2025 | Dynasplint |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $110.15 | 2023 | |
| Trice Medical, INC. | $103.35 | 2022-2024 | |
| Paratek Pharmaceuticals, INC. | $102.52 | 2022-2024 | Nuzyra |
| Globus Medical, INC. | $98.64 | 2025 | Senza |
| Wright Medical Technology, INC. | $95.04 | 2019 | |
| Abbvie INC. | $93.86 | 2021-2023 | Dalvance |
| Nabriva Therapeutics, Plc | $90.62 | 2021-2022 | |
| Extremity Medical | $70.33 | 2019 | |
| Fidia Pharma USA INC. | $64.76 | 2023 | Triluron, Hymovis |
| Kci USA, INC. | $37.65 | 2019-2020 | |
| Zyla Life Sciences, INC. | $37.07 | 2019-2020 | |
| Kuros Biosciences USA, INC | $34.69 | 2022-2023 | |
| Osteomed LLC | $34.52 | 2020 | |
| In2bones USA, LLC | $33.16 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $30.63 | 2022 | |
| Pfizer INC. | $29.99 | 2020 | |
| Glenmark Therapeutics INC. | $28.00 | 2019 | |
| Solventum Corporation | $23.91 | 2025 | Activ.A.C., Snap |
| Averitas Pharma INC. | $20.06 | 2023 | Qutenza |
| Trilliant Surgical LLC. | $19.18 | 2019 | |
| Integra Lifesciences Corporation | $17.89 | 2020 | |
| Lemaitre Vascular, INC. | $16.22 | 2025 | Restoreflow |
| Allergan, INC. | $16.16 | 2020 | |
| Becton, Dickinson and Company | $16.11 | 2024 | Venclose Maven Catheter |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.05 | 2023 | Jublia |
| Heron Therapeutics, INC. | $14.05 | 2021 | |
| Arthrosurface Incorporated | $14.02 | 2019 | |
| Ethicon US, LLC | $13.86 | 2023 | Vistaseal, Stratafix |
| Abbott Laboratories | $13.54 | 2023 | Proclaim |
| Ermi LLC | $13.38 | 2019 | |
| Arteriocyte Medical Systems, INC. | $13.03 | 2025 | Magellan |
| Medtronic, INC. | $12.81 | 2023 | Intellis Adaptivestim |
| Assertio Therapeutics, INC. | $11.42 | 2020 | |
| Kerecis Limited | $10.80 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mickey Stapp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.